Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36426 - 36450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	ABCG1	9619	upregulated	entinostat results in increased expression of ABCG1 mRNA	21q22.3	A21037
Entinostat	Investigational	ABHD14B	84836	upregulated	entinostat results in increased expression of ABHD14B mRNA	3p21.2	A21035
Entinostat	Investigational	ABHD15	116236	upregulated	entinostat results in increased expression of ABHD15 mRNA	17q11.2	A21035
Entinostat	Investigational	ABHD3	171586	upregulated	entinostat results in increased expression of ABHD3 mRNA	18q11.2	A21037 A21035
Entinostat	Investigational	ACAD11	84129	upregulated	entinostat results in increased expression of ACAD11 mRNA	3q22.1	A21037
Entinostat	Investigational	ACADSB	36	upregulated	entinostat results in increased expression of ACADSB mRNA	10q26.13	A21037
Entinostat	Investigational	ACAT2	39	downregulated	entinostat results in decreased expression of ACAT2 mRNA	6q25.3	A21035
Entinostat	Investigational	ACOX1	51	upregulated	entinostat results in increased expression of ACOX1 mRNA	17q25.1	A21037
Entinostat	Investigational	ACOXL	55289	upregulated	entinostat results in increased expression of ACOXL mRNA	2q13	A21037
Entinostat	Investigational	ACP5	54	upregulated	entinostat results in increased expression of ACP5 mRNA	19p13.2	A21037
Entinostat	Investigational	ACSL1	2180	upregulated	entinostat results in increased expression of ACSL1 mRNA	4q35.1	A21037
Entinostat	Investigational	ACSM3	6296	upregulated	entinostat results in increased expression of ACSM3 mRNA	16p12.3	A21037 A21035
Entinostat	Investigational	ACTA1	58	downregulated	entinostat results in decreased expression of ACTA1 mRNA	1q42.13	A21037
Entinostat	Investigational	ACTA2	59	downregulated	entinostat results in decreased expression of ACTA2 mRNA	10q23.31	A21037
Entinostat	Investigational	ACTC1	70	downregulated	entinostat results in decreased expression of ACTC1 mRNA	15q14	A21037
Entinostat	Investigational	ACTL6B	51412	upregulated	entinostat results in increased expression of ACTL6B mRNA	7q22.1	A21037
Entinostat	Investigational	ACTN1	87	upregulated	entinostat results in increased expression of ACTN1 mRNA	14q24.1	A21035
Entinostat	Investigational	ACVR2B	93	downregulated	entinostat results in decreased expression of ACVR2B mRNA	3p22.2	A21035
Entinostat	Investigational	ACVRL1	94	upregulated	entinostat results in increased expression of ACVRL1 mRNA	12q13.13	A21035
Entinostat	Investigational	ADA	100	upregulated	entinostat results in increased expression of ADA mRNA	20q13.12	A21035
Entinostat	Investigational	ADAM12	8038	downregulated	entinostat results in decreased expression of ADAM12 mRNA	10q26.2	A21037
Entinostat	Investigational	ADAM28	10863	upregulated	entinostat results in increased expression of ADAM28 mRNA	8p21.2	A21035
Entinostat	Investigational	ADAMTS17	170691	upregulated	entinostat results in increased expression of ADAMTS17 mRNA	15q26.3	A21037
Entinostat	Investigational	ADAMTS20	80070	upregulated	entinostat results in increased expression of ADAMTS20 mRNA	12q12	A21035
Entinostat	Investigational	ADAMTS9	56999	downregulated	entinostat results in decreased expression of ADAMTS9 mRNA	3p14.1	A21037

Displaying entries 36426 - 36450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability